The Expanding Role of New Medications in the Treatment of Type 2 Diabetes Mellitus
We examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Read More
Trends in Medication Utilization and the Cost of Treatment for Gout
With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Read More